These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 20586143)
21. Protective value of a folkloric medicinal plant extract against mortality and hemorrhage in a life-threatening renal trauma model. Tokgöz H; Karakaya K; Hanci V; Abduşoğlu M; Erol B; Türksoy O; Akduman B; Mungan NA Urology; 2010 Jun; 75(6):1515.e9-14. PubMed ID: 20223504 [TBL] [Abstract][Full Text] [Related]
22. The Effectiveness of Ankaferd Blood Stopper in the Management of Traumatic Bleeding. Koyuncu N Adv Ther; 2019 May; 36(5):1143-1149. PubMed ID: 30900196 [TBL] [Abstract][Full Text] [Related]
23. Medicinal plant extract (Ankaferd Blood Stopper) application in deep tissue injuries in rats: histopathological investigation of the effect on regional and systemic tissues. Okumuş M; Yüksel KZ; Özbağ D; Çıralık H; Yılmaz Z; Gümüşalan Y; Bakan V; Kalender AM Ulus Travma Acil Cerrahi Derg; 2013 Jan; 19(1):1-7. PubMed ID: 23588971 [TBL] [Abstract][Full Text] [Related]
24. Hemostasis vs. epidural fibrosis?: A comparative study on an experimental rat model of laminectomy. Erdogan H; Kelten B; Tuncdemir M; Erturkuner SP; Uzun H; Karaoglan A Neurol Neurochir Pol; 2016; 50(5):323-30. PubMed ID: 27591056 [TBL] [Abstract][Full Text] [Related]
25. In vivo hemostatic effect of the medicinal plant extract Ankaferd Blood Stopper in rats pretreated with warfarin. Cipil HS; Kosar A; Kaya A; Uz B; Haznedaroglu IC; Goker H; Ozdemir O; Koroglu M; Kirazli S; Firat HC Clin Appl Thromb Hemost; 2009; 15(3):270-6. PubMed ID: 19117967 [TBL] [Abstract][Full Text] [Related]
26. Haemostatic role and histopathological effects of a new haemostatic agent in a rat bladder haemorrhage model: an experimental trial. Kilic O; Gonen M; Acar K; Yurdakul T; Avunduk MC; Esen HH; Oz M BJU Int; 2010 Jun; 105(12):1722-5. PubMed ID: 19849692 [TBL] [Abstract][Full Text] [Related]
27. Histopathological evaluation of Ankaferd blood stopper use in the rabbit septoplasty model. Orhan I; Dogan R; Soylu E; Aksoy F; Veyseller B; Ozturan O; Esrefoglu M; Aydın MS Int J Pediatr Otorhinolaryngol; 2015 Mar; 79(3):305-9. PubMed ID: 25596649 [TBL] [Abstract][Full Text] [Related]
28. Evaluation of a haemostatic agent in rabbits. Turhan N; Bilgili H; Captug O; Kurt M; Shorbagi A; Beyazit Y; Kurt OK; Kosar A; Haznedaroglu IC Afr J Tradit Complement Altern Med; 2011; 8(1):61-5. PubMed ID: 22238484 [TBL] [Abstract][Full Text] [Related]
29. Bleeding due to slippage of elastic band during variceal ligation: successful use of Ankaferd blood stopper. Ozaslan E; Purnak T; Yildiz A; Haznedaroglu IC Indian J Gastroenterol; 2010 Jul; 29(4):166-8. PubMed ID: 20814774 [TBL] [Abstract][Full Text] [Related]
30. Evaluation of hemostatic effects of Ankaferd as an alternative medicine. Beyazit Y; Kurt M; Kekilli M; Goker H; Haznedaroglu IC Altern Med Rev; 2010 Dec; 15(4):329-36. PubMed ID: 21194248 [TBL] [Abstract][Full Text] [Related]
31. Effect of Ankaferd Blood Stopper on Skin Superoxide Dismutase and Catalase Activities in Warfarin-Treated Rats. Aktop S; Emekli-Alturfan E; Gönül O; Göçmen G; Garip H; Yarat A; Göker K Clin Appl Thromb Hemost; 2017 Mar; 23(2):168-174. PubMed ID: 26354714 [TBL] [Abstract][Full Text] [Related]
32. Efficacy of Ankaferd Blood Stopper on bone healing in diabetic rats: a stereological and histopathological study. Bulut E; Baş B; Altunkaynak BZ; Bekçioğlu B; Erdem Koç G; Gönülol E; Önger ME; Kaplan S Biotech Histochem; 2014 Oct; 89(7):535-43. PubMed ID: 24799094 [TBL] [Abstract][Full Text] [Related]
33. New coagulant agent (ankaferd blood stopper) for open hemorrhages in hemophilia with inhibitor. Öner AF; Doğan M; Kaya A; Sal E; Bektaş MS; Yesilmen O; Ayhan H; Acikgoz M Clin Appl Thromb Hemost; 2010 Dec; 16(6):705-7. PubMed ID: 19528064 [TBL] [Abstract][Full Text] [Related]
34. [Experimental study on hemostasis of thermosensitive chitosan hemostatic film]. Yin G; Wei C; Guo X; Chen H; Hou C Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2013 May; 27(5):624-7. PubMed ID: 23879105 [TBL] [Abstract][Full Text] [Related]
35. Percutaneous ankaferd injection to in vivo liver tissue in comparison to ethanol in an experimental rat model. Taş A; Köklü S; Beyazit Y; Karaca G; Astarcı HM; Akbal E; Koçak E; Topçu G; Haznedaroglu IC Clin Res Hepatol Gastroenterol; 2011 Sep; 35(8-9):549-53. PubMed ID: 21489900 [TBL] [Abstract][Full Text] [Related]
36. Comparison of hemostatic efficacy of topical Ankaferd Blood Stopper on heparinized and nonheparinized rats in bleeding related to liver injury. Ergin M; Özer N Acta Cir Bras; 2021; 36(1):e360106. PubMed ID: 33533829 [TBL] [Abstract][Full Text] [Related]
37. Intraarticular Ankaferd blood stopper application increases cartilagedegeneration: an experimental study. Kaya İ; Gülabi D; Yilmaz M; Baş A; Çeçen GS; Şener N Turk J Med Sci; 2016 Jan; 46(1):236-40. PubMed ID: 27511359 [TBL] [Abstract][Full Text] [Related]
38. Beneficial effects of Ankaferd Blood Stopper on caustic esophageal injuries: an experimental model. Akbal E; Köklü S; Karaca G; Astarci HM; Koçak E; Taş A; Beyazit Y; Topcu G; Haznedaroğlu IC Dis Esophagus; 2012 Apr; 25(3):188-94. PubMed ID: 21819483 [TBL] [Abstract][Full Text] [Related]
39. Ankaferd Blood Stopper for controlling gastrointestinal bleeding due to distinct benign lesions refractory to conventional antihemorrhagic measures. Kurt M; Onal I; Akdogan M; Kekilli M; Arhan M; Sayilir A; Oztas E; Haznedaroglu I Can J Gastroenterol; 2010 Jun; 24(6):380-4. PubMed ID: 20559581 [TBL] [Abstract][Full Text] [Related]
40. Use of Ankaferd Blood Stopper as a hemostatic agent: a clinical experience. Baykul T; Alanoglu EG; Kocer G J Contemp Dent Pract; 2010 Jan; 11(1):E088-94. PubMed ID: 20098971 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]